loadpatents
name:-0.031512022018433
name:-0.0047619342803955
name:-0.0026390552520752
Renes; Johan Patent Filings

Renes; Johan

Patent Applications and Registrations

Patent applications and USPTO patent grants for Renes; Johan.The latest application filed is for "multi-specific binding molecules targeting aberrant cells".

Company Profile
2.5.26
  • Renes; Johan - Oss NL
  • Renes; Johan - Amersfoort NL
  • Renes, Johan - Soest NL
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Multi-specific Binding Molecules Targeting Aberrant Cells
App 20210355209 - Willemsen; Ralph Alexander ;   et al.
2021-11-18
Multi-specific binding molecules targeting aberrant cells
Grant 11,098,115 - Willemsen , et al. August 24, 2
2021-08-24
Methods And Means For Attracting Immune Effector Cells To Tumor Cells
App 20210238543 - Renes; Johan ;   et al.
2021-08-05
Aberrant Cell-restricted Immunoglobulins Provided With A Toxic Moiety
App 20210205465 - Renes; Johan ;   et al.
2021-07-08
Aberrant cell-restricted immunoglobulins provided with a toxic moiety
Grant 10,946,104 - Renes , et al. March 16, 2
2021-03-16
Binding Molecules Targeting Pathogens
App 20200339669 - Renes; Johan ;   et al.
2020-10-29
Aberrant Cell-restricted Immunoglobulins Provided With A Toxic Moiety
App 20180154013 - Renes; Johan ;   et al.
2018-06-07
Binding Molecules Targeting Pathogens
App 20180105587 - Renes; Johan ;   et al.
2018-04-19
Polypeptide That Binds Aberrant Cells And Induces Apoptosis
App 20180071398 - Willemsen; Ralph Alexander ;   et al.
2018-03-15
Polypeptide that binds aberrant cells and induces apoptosis
Grant 9,821,073 - Willemsen , et al. November 21, 2
2017-11-21
Aberrant Cell-restricted Immunoglobulins Provided With A Toxic Moiety
App 20150202318 - RENES; JOHAN ;   et al.
2015-07-23
Binding Molecules Targeting Pathogens
App 20150175683 - Renes; Johan ;   et al.
2015-06-25
Aberrant Cell-restricted Immunoglobulins Provided With A Toxic Moiety
App 20150056198 - Renes; Johan ;   et al.
2015-02-26
Methods and Means for Clinical Investigations
App 20140336475 - Renes; Johan
2014-11-13
Multi-specific Binding Molecules Targeting Aberrant Cells
App 20140227273 - Willemsen; Ralph Alexander ;   et al.
2014-08-14
Polypeptide That Binds Aberrant Cells And Induces Apoptosis
App 20140205599 - Willemsen; Ralph Alexander ;   et al.
2014-07-24
Aberrant Cell-restricted Immunoglobulins Provided With A Toxic Moiety
App 20130183307 - Renes; Johan ;   et al.
2013-07-18
Separation Insurance System
App 20130046564 - Veldhuizen; Mark ;   et al.
2013-02-21
Mortgage insurance system
Grant 8,301,469 - Veldhuizen , et al. October 30, 2
2012-10-30
Methods and means for clinical investigations
App 20120123218 - Renes; Johan
2012-05-17
Cross-beta Structures As Carrier In Vaccines
App 20110287047 - Bouma; Barend ;   et al.
2011-11-24
Enhancement Of Immunogenicity Of Antigens
App 20110052564 - Gebbink; Martijn Frans Ben Gerard ;   et al.
2011-03-03
Immunogenic Compositions Capable Of Activating T-cells
App 20110008376 - Gebbink; Martijn Frans Ben Gerard ;   et al.
2011-01-13
Immunogenic compositions capable of activating T-cells
App 20090191228 - Gebbink; Martijn Frans Ben Gerard ;   et al.
2009-07-30
Immunogenic compositions
App 20090142377 - Gebbink; Martijn Frans Ben Gerard ;   et al.
2009-06-04
Signatory sequences
App 20050282169 - Turner, Allen C. ;   et al.
2005-12-22
Insurance for cessation of legal personal contract
App 20030074231 - Renes, Johan ;   et al.
2003-04-17
Fusion proteins for specific treatment of cancer and autoimmune diseases
App 20020176860 - Noteborn, Mathieu Hubertus, M. ;   et al.
2002-11-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed